SI1970060T1 - Uporaba C-(2-fenil-cikloheksil)-metilaminskih spojin za terapijo fibromialgije - Google Patents

Uporaba C-(2-fenil-cikloheksil)-metilaminskih spojin za terapijo fibromialgije

Info

Publication number
SI1970060T1
SI1970060T1 SI200431926T SI200431926T SI1970060T1 SI 1970060 T1 SI1970060 T1 SI 1970060T1 SI 200431926 T SI200431926 T SI 200431926T SI 200431926 T SI200431926 T SI 200431926T SI 1970060 T1 SI1970060 T1 SI 1970060T1
Authority
SI
Slovenia
Prior art keywords
cyclohexyl
dimethylaminomethyl
phenol
methoxyphenyl
phenyl
Prior art date
Application number
SI200431926T
Other languages
English (en)
Inventor
Petra Dr Bloms-Funke
Werner Dr Englberger
Hagen-Heinrich Dr Hennies
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of SI1970060T1 publication Critical patent/SI1970060T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SI200431926T 2003-11-28 2004-11-26 Uporaba C-(2-fenil-cikloheksil)-metilaminskih spojin za terapijo fibromialgije SI1970060T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10356362A DE10356362A1 (de) 2003-11-28 2003-11-28 Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie von Angststörungen
EP08008351A EP1970060B9 (de) 2003-11-28 2004-11-26 Verwendung von C-(2-Phenyl-cyclohexyl)-methylaminverbindungen zur Therapie von Fibromyalgia

Publications (1)

Publication Number Publication Date
SI1970060T1 true SI1970060T1 (sl) 2012-10-30

Family

ID=34609453

Family Applications (2)

Application Number Title Priority Date Filing Date
SI200431926T SI1970060T1 (sl) 2003-11-28 2004-11-26 Uporaba C-(2-fenil-cikloheksil)-metilaminskih spojin za terapijo fibromialgije
SI200431677T SI1686984T1 (sl) 2003-11-28 2004-11-26 Uporaba C-(2-fenil-cikloheksil)-metilaminskih spojin za terapijo anksioznostnih motenj

Family Applications After (1)

Application Number Title Priority Date Filing Date
SI200431677T SI1686984T1 (sl) 2003-11-28 2004-11-26 Uporaba C-(2-fenil-cikloheksil)-metilaminskih spojin za terapijo anksioznostnih motenj

Country Status (14)

Country Link
US (3) US20060258741A1 (sl)
EP (2) EP1970060B9 (sl)
JP (1) JP5013875B2 (sl)
AT (1) ATE509626T1 (sl)
CA (1) CA2546672C (sl)
CY (2) CY1113348T1 (sl)
DE (1) DE10356362A1 (sl)
DK (2) DK1970060T3 (sl)
ES (2) ES2362752T3 (sl)
HR (1) HRP20110608T1 (sl)
PL (2) PL1970060T3 (sl)
PT (2) PT1686984E (sl)
SI (2) SI1970060T1 (sl)
WO (1) WO2005051375A1 (sl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050182131A1 (en) * 2002-07-19 2005-08-18 Gruenenthal Gmbh 1-Phenyl-2-dimethylaminomethyl cyclohexane compounds and therapies for depressive symptoms, pain and incontinence
DE102005034973A1 (de) * 2005-07-22 2007-02-15 Grünenthal GmbH Salz von Dimethylaminomethyl-phenyl-cyclohexan und dessen kristalline Formen
DE102005034974A1 (de) * 2005-07-22 2007-04-19 Grünenthal GmbH Salz von Dimethylaminomethyl-phenyl-cyclohexan und dessen kristalline Formen
DE102005061428A1 (de) * 2005-12-22 2007-08-16 Grünenthal GmbH Substituierte Cyclohexylmethyl-Derivate

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19525137C2 (de) 1995-07-11 2003-02-27 Gruenenthal Gmbh 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe
US6387956B1 (en) * 1999-03-24 2002-05-14 University Of Cincinnati Methods of treating obsessive-compulsive spectrum disorders
DE10059411A1 (de) * 2000-11-30 2002-06-13 Gruenenthal Gmbh Verwendung von 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbindungen zur Therapie der Harninkontinenz
DE10109763A1 (de) * 2001-02-28 2002-09-05 Gruenenthal Gmbh Pharmazeutische Salze
DE10146275A1 (de) * 2001-09-18 2003-04-24 Gruenenthal Gmbh Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz
WO2003048113A1 (en) * 2001-11-30 2003-06-12 Sepracor Inc. Tramadol analogs and uses thereof
DE10233048A1 (de) * 2002-07-19 2004-01-29 Grünenthal GmbH Verwendung von 1-Phenyl-3dimethylamino-propanverbindungen zur Therapie von depressiven Symptomatiken
DE10254785A1 (de) * 2002-11-22 2004-06-03 Grünenthal GmbH Kombination ausgewählter Analgetika mit COX II-Inhibitoren
AU2003283410A1 (en) * 2002-11-22 2004-06-18 Grunenthal Gmbh Combination of selected analgesics and cox-ii inhibitors
DE102005011517A1 (de) * 2005-03-10 2006-09-21 Grünenthal GmbH Transdermales therapeutisches System zur Verabreichung von Analgetika
US20090104266A1 (en) * 2005-09-15 2009-04-23 Tobias Jung 3-(2-dimethylaminomethylcy clohexyl)phenol retard formulation

Also Published As

Publication number Publication date
PT1686984E (pt) 2011-05-30
CY1113348T1 (el) 2016-06-22
PT1970060E (pt) 2012-10-02
DE10356362A1 (de) 2005-06-23
JP5013875B2 (ja) 2012-08-29
PL1970060T3 (pl) 2012-11-30
SI1686984T1 (sl) 2011-07-29
CY1113162T1 (el) 2016-04-13
CA2546672C (en) 2013-01-22
HRP20110608T1 (hr) 2011-10-31
JP2007512288A (ja) 2007-05-17
ES2362752T3 (es) 2011-07-12
WO2005051375A1 (de) 2005-06-09
PL1686984T3 (pl) 2011-10-31
CA2546672A1 (en) 2005-06-09
EP1970060B9 (de) 2013-01-09
EP1970060A2 (de) 2008-09-17
ES2390931T3 (es) 2012-11-19
EP1686984A1 (de) 2006-08-09
DK1686984T3 (da) 2011-06-20
US20100249225A1 (en) 2010-09-30
EP1970060B1 (de) 2012-08-29
EP1970060A3 (de) 2009-04-15
US20100004341A1 (en) 2010-01-07
ATE509626T1 (de) 2011-06-15
EP1686984B1 (de) 2011-05-18
US20060258741A1 (en) 2006-11-16
US8084497B2 (en) 2011-12-27
DK1970060T3 (da) 2012-10-01

Similar Documents

Publication Publication Date Title
CY1113162T1 (el) Χρησιμοποιηση ενωσεων c-(2-φαινυλο-κυκλοεξυλο)-μεθυλαμινης για τη θεραπεια φοβικων διαταραχων
CA2173747C (en) Calcium receptor-active arylalkyl amines
AU721452B2 (en) Antidiabetic agents
SI2010531T1 (sl) Spirociklični cikloheksanski derivati z analgetskim učinkom
US7214824B2 (en) Substituted N-sulfonylaminobenzyl-2-phenoxyacetamide compounds as VR1 receptor agonists
AU4195796A (en) Calcium receptor-active compounds
JP2007523955A (ja) 疾患の治療のためのアミンおよびアミド
MXPA06012505A (es) Compuestos de morfolina sustituida para el tratamiento de trastornos del sistema nervioso central.
ES2368460T3 (es) Compuestos de fenilmetil biciclocarboxiamida sustituidos.
US20070032555A1 (en) Novel aryloxyphenyl-propanamines
AU2010236404A1 (en) Monoamine reuptake inhibitors
RU2007139543A (ru) Производные бензодиоксана и бензодиоксолана и их применение
EP2104503A1 (en) Morpholine dopamine agonists for the treatment of pain
WO2006051378A1 (en) Substituted n-sulfonylaminobenzyl-2-phenoxy acetamide compounds
JP2012144545A (ja) アルファ−２−デルタリガンドとセロトニン／ノルアドレナリン再取込み阻害薬を含む組合せ
RU2006107534A (ru) Комбинация, включающая альфа-2-дельта-лиганд анд и ssri и/или snri, для лечения депрессии и тревожного расстройства
JP2006522030A5 (sl)
JP2009542819A (ja) ムスカリン性受容体ｍ１拮抗剤を使用する精神状態の処置
US8273786B2 (en) 3-phenoxymethylpyrrolidine compounds
Andrews et al. The Discovery of UK-390957: the Challenge of Targeting a Short Half-life, Rapid Tmax SSRI
JPH06293751A (ja) 光学活性ベンゾジオキサン誘導体並びにその化合物を含有する抗鬱剤及び抗不安剤
JPWO2004106283A1 (ja) アミノアルコール誘導体、それを含有する医薬組成物およびそれらの用途